NCT03703791View on ClinicalTrials.gov

Real World, Open Label, QOL Assessment of Peanut Immunotherapy AR101 in Children and Adolescents

PHASE3TerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

October 24, 2018

Primary Completion Date

November 23, 2018

Study Completion Date

November 23, 2018

Conditions
Peanut Allergy
Interventions
BIOLOGICAL

AR101

AR101 powder

Trial Locations (11)

8035

Hospital Universitario Vall d'Hebron - PPDS, Barcelona

8208

Corporacio Sanitaria Parc Tauli, Sabadell

8916

Hospital Universitario Germans Trias i Pujol, Badalona

28009

Hospital Infantil Universitario Niño Jesus, Madrid

28032

Hospital Universitario Infanta Leonor, Madrid

28040

Hospital Clinico San Carlos, Madrid

28911

Hospital Universitario Severo Ochoa, Leganés

31008

Complejo Hospitalario de Navarra, Pamplona

38320

Hospital Universitario de Canarias, Santa Cruz de Tenerife

41009

Hospital Universitario Virgen Macarena, Seville

46026

Hospital Universitari i Politecnic La Fe de Valencia, Valencia

Sponsors
All Listed Sponsors
lead

Aimmune Therapeutics, Inc.

INDUSTRY

NCT03703791 - Real World, Open Label, QOL Assessment of Peanut Immunotherapy AR101 in Children and Adolescents | Biotech Hunter | Biotech Hunter